Vimarsana
Biggest News Aggregation in the World

Page 4 - Purchase Additional News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Purchase Additional. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Purchase Additional Today - Breaking & Trending Today

Arvinas, Inc. Announces Exercise of Underwriters' Option to Purchase Additional Shares - Vimarsana News

Arvinas, Inc. Announces Exercise of Underwriters' Option to Purchase Additional Shares

[December 28, 2020] Arvinas, Inc. Announces Exercise of Underwriters' Option to Purchase Additional Shares NEW HAVEN, Conn., Dec. 28, 2020 (GLOBE NEWSWIRE) -- Arvinas, Inc. (Nasdaq: ARVN), a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation using its PROTAC ® Discovery Engine, today announced that the underwriters of its previously announced underwritten public offering of common stock, which closed on December 18, 2020, have exercised in full their option to purchase additional shares of common stock at the public offering price, less...

Source: tmcnet.com
Atlas Announces Closing of Seaspan's $201.25 Million 3.75% Exchangeable Senior Notes Offering - Vimarsana News

Atlas Announces Closing of Seaspan's $201.25 Million 3.75% Exchangeable Senior Notes Offering

Seaspan Corporation (CNW Group/Atlas Corp.) Offering includes $26.25 Million Full Exercise of Option to Purchase Additional Notes LONDON, Dec. 22, 2020 /PRNewswire/ - Atlas Corp. ("Atlas") (NYSE: ATCO) announced that its wholly-owned subsidiary, Seaspan Corporation ("Seaspan" or the "Company"), closed its previously announced offering (the "Offering") of 3.75% exchangeable senior notes due 2025 (the "notes") in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the "Securities Act").  As ...

NANOBIOTIX Announces Pricing of Global Offering and Approval to List on NASDAQ Global Select Market - Vimarsana News

NANOBIOTIX Announces Pricing of Global Offering and Approval to List on NASDAQ Global Select Market

NANOBIOTIX (Paris:NANO) (Euronext: NANO – ISIN : FR0011341205 – the ‘‘ Company’’), a clinical-stage nanomedicine company pioneering new approaches to the treatment of cancer, today announced the pricing of its initial public offering on the Nasdaq Global Select Market by way of a capital increase of 7,300,000 new ordinary shares (the “ New Shares”), consisting of a public offering of 5,445,000 ordinary shares in the form of American Depositary Shares (“ ADSs”), each representing the right to receive one ordinary share, in the United States (the “ U.S. Offering”) and a ...